Literature DB >> 9284388

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.

E J van der Wouden1, A A van Zwet, G D Vosmaer, J A Oom, A de Jong, J H Kleibeuker.   

Abstract

The prevalence of primary metronidazole resistance of Helicobacter pylori was studied in one Dutch hospital from 1993 to 1996 and in two additional Dutch hospitals in 1993 and 1996. All cultures of antral biopsy specimens yielding H. pylori in the study period were evaluated, except those from patients who had received anti-H. pylori treatment; 1,037 H. pylori strains, all from different patients were included. Metronidazole resistance was determined by disk diffusion in 1993 and by Epilipsometer-test in 1994 to 1996. Metronidazole resistance increased from 7% (18/245) in 1993 to 32% (161/509) in 1996. More patients with nonulcer dyspepsia and more non-Western European patients were seen in 1996 than in 1993, but age and sex differences were not observed. A comparable increase in metronidazole resistance was observed in both nonulcer dyspepsia patients and peptic ulcer patients, and the prevalence of metronidazole resistance in Western Europeans increased from 5% in 1993 to 28% in 1996.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284388      PMCID: PMC2627643          DOI: 10.3201/eid0303.970320

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  20 in total

Review 1.  The who's and when's of therapy for Helicobacter pylori.

Authors:  D Y Graham; G M Börsch
Journal:  Am J Gastroenterol       Date:  1990-12       Impact factor: 10.864

2.  Metronidazole resistance in Helicobacter pylori.

Authors:  Y Glupczynski; A Burette; E De Koster; J F Nyst; M Deltenre; S Cadranel; L Bourdeaux; D De Vos
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

3.  Helicobacter pylori and metronidazole resistance.

Authors:  J Weil; G D Bell; K Powell; R Jobson; J E Trowell; P Gant; P H Jones
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

4.  Role of metronidazole resistance in therapy of Helicobacter pylori infections.

Authors:  H Rautelin; K Seppälä; O V Renkonen; U Vainio; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Metronidazole-resistant H pylori--of questionable clinical importance.

Authors:  R P Walt
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

6.  An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.

Authors:  T K Ling; A F Cheng; J J Sung; P Y Yiu; S S Chung
Journal:  Helicobacter       Date:  1996-03       Impact factor: 5.753

7.  Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole.

Authors:  A M Hirschl; M M Hirschl; M L Rotter
Journal:  J Antimicrob Chemother       Date:  1993-07       Impact factor: 5.790

8.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

9.  Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.

Authors:  J C Thijs; A A Van Zwet; H B Oey
Journal:  Scand J Gastroenterol       Date:  1993-11       Impact factor: 2.423

10.  Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance.

Authors:  A J DeCross; B J Marshall; R W McCallum; S R Hoffman; L J Barrett; R L Guerrant
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more
  15 in total

1.  Antibiotics resistance rate of Helicobacter pylori in Bhutan.

Authors:  Ratha-korn Vilaichone; Yoshio Yamaoka; Seiji Shiota; Thawee Ratanachu-ek; Lotay Tshering; Tomohisa Uchida; Toshio Fujioka; Varocha Mahachai
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.

Authors:  K K Mishra; S Srivastava; A Garg; A Ayyagari
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

3.  Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.

Authors:  P J Jenks; R L Ferrero; J Tankovic; J M Thiberge; A Labigne
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

5.  Differentiation of metronidazole-sensitive and -resistant clinical isolates of Helicobacter pylori by immunoblotting with antisera to the RdxA protein.

Authors:  S R Latham; R J Owen; N C Elviss; A Labigne; P J Jenks
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing.

Authors:  E J van der Wouden; A de Jong; J C Thijs; J H Kleibeuker; A A van Zwet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico.

Authors:  J Torres; M Camorlinga-Ponce; G Pérez-Pérez; A Madrazo-De la Garza; M Dehesa; G González-Valencia; O Muñoz
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

8.  Association of metronidazole resistance and natural competence in Helicobacter pylori.

Authors:  Yu-Ching Yeh; Kai-Chin Chang; Jyh-Chin Yang; Chi-Tai Fang; Jin-Town Wang
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam.

Authors:  Tran T Binh; Seiji Shiota; Lam T Nguyen; Dung D Q Ho; Hai H Hoang; Long Ta; Dung T Trinh; Toshio Fujioka; Yoshio Yamaoka
Journal:  J Clin Gastroenterol       Date:  2013-03       Impact factor: 3.062

10.  Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population.

Authors:  Sook-Yin Lui; Khay-Guan Yeoh; Bow Ho
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.